Masaru Matsumoto

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Aberrant expression of the PREX2-MAGI2 axis modulates myofibroblast differentiation in pulmonary fibrosis.

Aberrant expression of the PREX2-MAGI2 axis modulates myofibroblast differentiation in pulmonary fibrosis.

Journal: American journal of physiology. Lung cellular and molecular physiology

Published: August 22, 2026

Targeting driver mutations in lung cancer with interstitial pneumonia: A nationwide study in Japan.

Targeting driver mutations in lung cancer with interstitial pneumonia: A nationwide study in Japan.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 18, 2025

Phase II Study of Short Hydration without Diuretics for Cisplatin-Based Chemotherapy.

Phase II Study of Short Hydration without Diuretics for Cisplatin-Based Chemotherapy.

Journal: Journal of Nippon Medical School = Nippon Ika Daigaku zasshi

Published: May 21, 2025

Ivermectin Enhances Paclitaxel Efficacy by Overcoming Resistance Through Modulation of ABCB1 in Non-small Cell Lung Cancer.

Ivermectin Enhances Paclitaxel Efficacy by Overcoming Resistance Through Modulation of ABCB1 in Non-small Cell Lung Cancer.

Journal: Anticancer research

Published: October 12, 2024

Carboplatin in combination with etoposide for advanced small cell lung cancer complicated with idiopathic interstitial pneumonia: a single-arm phase II study.

Carboplatin in combination with etoposide for advanced small cell lung cancer complicated with idiopathic interstitial pneumonia: a single-arm phase II study.

Journal: BMC pulmonary medicine

Published: September 27, 2024

Efficacy and safety of pleurodesis for lung cancer patients with interstitial lung disease.

Efficacy and safety of pleurodesis for lung cancer patients with interstitial lung disease.

Journal: Journal of thoracic disease

Published: September 18, 2024

Venous thromboembolism in patients undergoing surgery for lung cancer: a post hoc analysis of the Cancer-VTE Registry.

Venous thromboembolism in patients undergoing surgery for lung cancer: a post hoc analysis of the Cancer-VTE Registry.

Journal: Japanese journal of clinical oncology

Published: March 24, 2024

IgA vasculitis induced by carboplatin + nab-paclitaxel + pembrolizumab in a patient with advanced lung squamous cell carcinoma: a case report.

IgA vasculitis induced by carboplatin + nab-paclitaxel + pembrolizumab in a patient with advanced lung squamous cell carcinoma: a case report.

Journal: Frontiers in immunology

Published: January 15, 2024

Immune checkpoint inhibitors in patients with lung cancer having chronic interstitial pneumonia.

Immune checkpoint inhibitors in patients with lung cancer having chronic interstitial pneumonia.

Journal: ERJ open research

Published: December 05, 2023

Afatinib plus PEM and CBDCA overcome osimertinib resistance in EGFR-mutated NSCLC with high thrombospondin-1 expression.

Afatinib plus PEM and CBDCA overcome osimertinib resistance in EGFR-mutated NSCLC with high thrombospondin-1 expression.

Journal: Cancer science

Published: November 29, 2023

Induction of resistance to neurotrophic tropomyosin-receptor kinase inhibitors by HMGCS2 via a mevalonate pathway.

Induction of resistance to neurotrophic tropomyosin-receptor kinase inhibitors by HMGCS2 via a mevalonate pathway.

Journal: Cancer medicine

Published: October 11, 2023

Phosphoproteomic Analysis Identified Mutual Phosphorylation of FAK and Src as a Mechanism of Osimertinib Resistance in EGFR-Mutant Lung Cancer.

Phosphoproteomic Analysis Identified Mutual Phosphorylation of FAK and Src as a Mechanism of Osimertinib Resistance in EGFR-Mutant Lung Cancer.

Journal: JTO clinical and research reports

Published: September 11, 2023

Showing 1-12 of 40

Last Updated: 09/26/2026